[{"indications": "Indications\u00a0maintenance treatment of chronic obstructive pulmonary disease", "name": "TIOTROPIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.1 Bronchodilators", "3.1.2 Antimuscarinic bronchodilators", "TIOTROPIUM"], "cautions": "Cautions\u00a0\n(From 3.1.2 Antimuscarinic bronchodilators: British National Formulary)\nCautions\u00a0Antimuscarinic bronchodilators should be used with caution in patients with prostatic hyperplasia, bladder outflow obstruction, and those susceptible to angle-closure glaucoma (see below); interactions: Appendix 1 (antimuscarinics).Glaucoma\u00a0Acute angle-closure glaucoma has been reported with nebulised ipratropium, particularly when given with nebulised salbutamol (and possibly other beta2 agonists); care needed to protect patient\u2019s eyes from nebulised drug or from drug powder.; also cardiac rhythm disorders (with Spiriva\u00ae Respimat\u00ae)", "side-effects": "Side-effects\u00a0\n(From 3.1.2 Antimuscarinic bronchodilators: British National Formulary)\nSide-effects\u00a0Dry mouth is the most common side-effect of antimuscarinic bronchodilators; also constipation, cough, paradoxical bronchospasm, headache, dizziness; less commonly nausea, tachycardia, palpitation, atrial fibrillation, urinary retention, eye pain, corneal oedema, angle-closure glaucoma, blurred vision, stomatitis, rash, and pruritus can occur. Raised intra-ocular pressure and urticaria have occurred rarely.; less commonly taste disturbance, gastro-oesophageal reflux\r\ndisease, pharyngitis, dysphonia, dysphagia, dysuria, epistaxis, oropharyngeal\r\ncandidiasis; rarely intestinal obstruction (including\r\nparalytic ileus), laryngitis, insomnia, urinary-tract infection, skin\r\ninfection, sinusitis, dental caries, gingivitis, glossitis, skin ulcer; also reported dehydration, joint swelling, dry skin", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/119675.htm", "doses": ["See under preparations below", "by inhalation of powder, adult over 18 years, 18\u00a0micrograms once daily", "by inhalation, adult over 18 years, 5\u00a0micrograms (2 puffs) once daily"]}]